Name: San Diego company's COVID-19 test gets emergency approval
Brand: 10news.com
SKU: 10news-com-28
Availability: OnlineOnly

critic

San Diego company's COVID-19 test gets emergency approval

preview

FDA ok's sequencing-based COVID-19 test5:59 PM, Jun 11, 2020SAN DIEGO (KGTV)-- A San Diego-based genetics company received the FDA's Emergency Use Authorization for its revolutionary type of COVID-19 testing. The new test not only provides a positive or negative reading, but it also provides vital genetic information that can help create a vaccine.From concept to the FDA's emergency use authorization, the San Diego-based team at Illumina worked at warp speed."The idea came 58 days ago," Susan Tousi, Sr. VP. of Production and Development at Illumina said. "It took a village of all of us in San Diego to make that happen."There are already on the market.But the scientists and engineers at Illumina came up with a test that reveals a lot more."Our test not only gives you a yes or no answer for the presence of the virus, but it also gives you the genetic sequence of the virus," Tousi said.On Tuesday, the of the world's first COVID-19 test that also shows the biological makeup of the virus.The results can help researchers track and trace the virus and study different mutations over time and in different regions."Knowing this is really critical, not only to the development of effective vaccines but also for us to detect its presence, recurrence, and whether there is a mutated form that we need to be prepared for," Tousi said.The sample is collected via nose or throat swab and sent to the lab.A sequencing machine can run up 43,000 samples a week. From swab to results, it takes only 24 hours."This was the culmination of an incredible amount of work. And I'm confident we're going to make a big difference in the fight against COVID," Tousi said. "The understanding of this virus at the genetic level is going to make all of the difference in the world in fighting this and future disease."The company has already started to ship its tests to large labs across the world.Copyright 2020 Scripps Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

FDA ok's sequencing-based COVID-19 test5:59 PM, Jun 11, 2020SAN DIEGO (KGTV)-- A San Diego-based genetics company received the FDA's Emergency Use Authorization for its revolutionary type of COVID-19 testing. The new test not only provides a positive or negative reading, but it also provides vital genetic information that can help create a vaccine.From concept to the FDA's emergency use authorization, the San Diego-based team at Illumina worked at warp speed."The idea came 58 days ago," Susan Tousi, Sr. VP. of Production and Development at Illumina said. "It took a village of all of us in...

public

Rina Nakano

10news.com

Credible

Speculation

Anecdotal Evidence

Generalization

Stacking the Deck

Appeal to Authority

Straw Man

Slippery Slope

Emotional Appeal

Red Herring

False Dilemma

Illogical

Moral Equivalency

Ad Hominem

Correlation w/o Causation

Semantics

Begging the Question

Faulty Analogy

Non Sequitur

Bandwagon

Dogmatism

Failing Occam's Razor

Biased

Pure Opinion

Hit Piece

Racial Bias

National Bias

Religious Bias

Financial Incentive

Political Agenda

Gender Bias

Misused Image/Video

Study Misinterpreted

Mistake

Misused Term

Science Misrepresented

Factual Error

Satire

Surface Level

Lack of Reliable Sources

Sensational

Not Credible

Investigative

Balanced

Well Sourced

Great Context

sports

entertainment

U.S.

international

business

technology

science

culture

politics

media

health

San Diego company's COVID-19 test gets emergency approval

No article scores yet.

CRITIC REVIEWS

PUBLIC REVIEWS